SCHEMBL7459957

SCHEMBL7459957

CC1(C)C2CCC1(C)C2(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8717792 0.77
SCHEMBL10452616 0.77
SCHEMBL9364438 0.75
Acetaldehyde SCHEMBL10837526 0.67 TSHR (0.30)
SCHEMBL15542337 0.64 CHRNB2 (0.32)
SCHEMBL15542630 0.64 CHRNB2 (0.32)
SCHEMBL7903403 0.60 L3MBTL1 (0.33)
SCHEMBL14398026 0.60 L3MBTL1 (0.33)
SCHEMBL50283 0.60 L3MBTL1 (0.33)
SCHEMBL2038757 0.60 L3MBTL1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0957903-A4 PHARMACEUTICAL COMPOSITIONS AND METHODS CODON PHARMACEUTICALS INC (US) 2002-10-09 EP claimed
EP-0957903-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS Codon Pharmaceuticals, Inc. (US) 1999-11-24 EP claimed
WO-1998011882-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS CODON PHARMACEUTICALS, INC. (US) 1998-03-26 WO claimed
EP-0957903-A4 PHARMACEUTICAL COMPOSITIONS AND METHODS CODON PHARMACEUTICALS INC (US) 2002-10-09 EP disclosed
EP-0957903-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS Codon Pharmaceuticals, Inc. (US) 1999-11-24 EP disclosed
WO-1998011882-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS CODON PHARMACEUTICALS, INC. (US) 1998-03-26 WO disclosed